The Skinny on GLP-1 Medications GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural hormone in the body, prompting increased insulin release
A 2000 study in the British Journal of Dermatology found that nicotinamide increased ceramide biosynthesis in skin cells by up to 5.5-fold and reduced water loss from the skin barrier
Yet, even more aggressive insulin protocols have been described, suggesting to increase the insulin infusion rate in a step-wise manner up to 10 units/kg/h if no clinical improvement is observed
After that, everything goes through your liver for processing, which can further reduce the amount of nutrients that actually make it to your cells
Semaglutide was first released in 2017 under the brand name Ozempic, and Tirzepatide was released in 2022 as Mounjaro
The world's first low molecular weight GHK-Cu topical serum, blended with hyaluronic acid, hydrolyzed collagen and other powerful ingredients, designed to support your skin every single day